Anzeige
Mehr »
Lynx Broker
Login
Samstag, 19.10.2019 Börsentäglich über 12.000 News von 614 internationalen Medien
Magisch! Weg frei für die >Milliarden-Chance< im Pennystockmantel!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1J9SF ISIN: AU000000SUD7 Ticker-Symbol: E4N 
Frankfurt
18.10.19
08:07 Uhr
0,004 Euro
+0,003
+250,00 %
Branche
Gesundheitswesen
Aktienmarkt
AUSTRALIEN
1-Jahres-Chart
SUDA PHARMACEUTICALS LTD Chart 1 Jahr
5-Tage-Chart
SUDA PHARMACEUTICALS LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,001
0,004
18.10.
0,001
0,004
18.10.

Aktuelle News zur SUDA PHARMACEUTICALS Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoSUDA PHARMACEUTICALS LTD: Proposed Share Consolidation4
MoSUDA PHARMACEUTICALS LTD: Notice of Annual General Meeting/Proxy Form1
Börsennews zur SUDA PHARMACEUTICALS Aktie und weiteren Hot Stocks erhalten
03.10.SUDA PHARMACEUTICALS LTD: ArTiMist Appeal Reasons For Decision1
02.10.SUDA PHARMACEUTICALS LTD: Response to ASX Query regarding Accounts3
30.09.SUDA PHARMACEUTICALS LTD: TGA Declines ArTiMist Appeal3
29.09.Dr Boreham's Crucible: Suda shows far more promise than its 'penny-dreadful' status suggests6
24.09.SUDA PHARMACEUTICALS LTD: Appendix 4G and Corporate Governance Statement-
24.09.SUDA PHARMACEUTICALS LTD: Annual Report to shareholders1
24.09.SUDA PHARMACEUTICALS LTD: Final Director's Interest Notice-
23.09.SUDA PHARMACEUTICALS LTD: Manaing Director and CEO Resignation1
11.09.SUDA PHARMACEUTICALS LTD: Change of Director's Interest Notice3
29.08.SUDA PHARMACEUTICALS LTD: Preliminary Final Report6
29.08.Web Presence: Brandy Zwicker is the Creative Force Behind Shawn Suda's Eye-Opening New Book, Evidence of Genesis195BISMARK, ND / ACCESSWIRE / August 29, 2019 / A tale as old as time, now told through an explosive new lens. Upon its release on February 3, 2019, Shawn Suda's book, Evidence of Genesis, created colossal...
► Artikel lesen
29.08.SUDA PHARMACEUTICALS LTD: Article on Anagrelide3
27.08.SUDA PHARMACEUTICALS LTD: Corporate Presentation2
13.08.SUDA PHARMACEUTICALS LTD: New Project Director For Anagrelide Project6
09.08.SUDA PHARMACEUTICALS LTD: ArTiMist Appeal Lodged With TGA5
06.08.SUDA PHARMACEUTICALS LTD: Government Initiatives To Boost Medical Marijuana Industry4
06.08.SUDA PHARMACEUTICALS LTD: ZolpiMist Clinical Results Published4
31.07.SUDA PHARMACEUTICALS LTD: Appendix 4C - quarterly-
Seite:  Weiter >>
54 Nachrichten in den letzten 12 Monaten

Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1